Publications by authors named "Kostantina Gorgoli"
Expert Opin Biol Ther
June 2018
Article Synopsis
- Ranibizumab is an anti-VEGF medication that was first approved to treat neovascular age-related macular degeneration and has greatly improved treatment for various retinal disorders.
- Its potential benefits extend to other eye conditions like ocular scarring post-glaucoma surgery and neovascular glaucoma (NVG), with evidence suggesting it can help in NVG management.
- However, its effectiveness in glaucoma surgery is less established compared to mitomycin C, and factors like cost, off-label use, and uncertain dosing may limit its practicality, although improved delivery methods could enhance its future use.
